Dr. Tyler Rowland Hollen, MD

Dr. Hollen practices at Genesiscare Usa of Florida in Cape Coral, Florida.

Dr. Hollen's NPI, 1033344643, was assigned on May 27, 2009. Dr. Hollen graduated from University Of Florida College Of Medicine in 2009. Dr. Hollen holds Florida license ME119644.

Dr. Hollen's primary practice is Genesiscare Usa of Florida, at 1419 SE 8th Ter, Cape Coral, FL 33990 in Lee County. The practice phone is (239) 489-3420.

Dr. Hollen's primary practice is Genesiscare Usa of Florida in Cape Coral, Florida. Dr. Hollen is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is GenesisCare. Dmand AI also links Dr. Hollen to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hollen practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Hollen's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Hollen is board certified in radiation oncology by the American Board of Radiology. Dr. Hollen is licensed in Florida.

Dmand AI lists anal cancer radiation, bladder cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI and colorectal cancer radiation among the conditions Dr. Hollen treats.

CMS data shows 13,599 Medicare services from Dr. Hollen across 27 procedure codes in 2024, for 614 Medicare patients. Medicare paid $2,343,568 for them. Every service was in an office.

CMS counts 614 Medicare patients who saw Dr. Hollen in 2024. The largest group is 75 to 84, with 286 patients. 75% of them have cancer, and 75% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hollen's median patient age at 75, with 38% women.

In 2024, Dr. Hollen wrote 268 Medicare Part D claims for 120 patients. 84% of them were for generic drugs. CMS names the drug for 210 of them, across 7 drugs with 11 or more claims each, at $58,895 in total drug cost. In 2023, CMS named 164 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Hollen for performance year 2024, reported individually. Dr. Hollen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hollen as offering telehealth.

Dmand AI links 2 papers to Dr. Hollen in 2006. Dr. Hollen's most frequent co-authors are Robert J. Amdur, MD, William M. Mendenhall, MD and Mikhail Vaysberg, DO.

CMS Open Payments shows 59 general payments to Dr. Hollen from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novocure Inc. paid the most, $300.

Dr. Hollen graduated from University Of Florida College Of Medicine in 2009.

Dr. Hollen is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.